Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carfilzomib + Bendamustine + Dexamethasone in Newly Diagnosed MM
NCT02002598Phase 2Terminated
- Start
- Nov 2013
- Primary completion
- Mar 2019
- Modality
- Irreversible Covalent Inhibitors, Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 2 trial of carfilzomib in multiple myeloma (MM). Started Nov 2013; status: terminated.
02
Drugs
carfilzomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02002598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02002598.